Ligand profile
ZINC8816280
Virtual-screening candidate from ZINC.
Bound to: KP13_04217 — Thioredoxin reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC8816280- UniProt (similar protein)
C4LW95- Tanimoto
- 0.729
- Target protein
- KP13_04217
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 107.4
- −1 ≤ LogP ≤ 5 4.35
- MW ≤ 500 Da 477.5
- LogP ≤ 5 4.35
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 9
- TPSA ≤ 140 Ų 107.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCOc1cc(/C=C2\S/C(=N\c3ccccc3)N(Cc3ccco3)C2=O)ccc1OCC(N)=OCCOc1cc(/C=C2\S/C(=N\c3ccccc3)N(Cc3ccco3)C2=O)ccc1OCC(N)=O
InChI=1S/C25H23N3O5S/c1-2-31-21-13-17(10-11-20(21)33-16-23(26)29)14-22-24(30)28(15-19-9-6-12-32-19)25(34-22)27-18-7-4-3-5-8-18/h3-14H,2,15-16H2,1H3,(H2,26,29)/b22-14-,27-25-InChI=1S/C25H23N3O5S/c1-2-31-21-13-17(10-11-20(21)33-16-23(26)29)14-22-24(30)28(15-19-9-6-12-32-19)25(34-22)27-18-7-4-3-5-8-18/h3-14H,2,15-16H2,1H3,(H2,26,29)/b22-14-,27-25-
SOFPMMNVVSJISG-BUNZEZOSSA-NSOFPMMNVVSJISG-BUNZEZOSSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL3913125
- Homolog
- C4LW95
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC8816280 →
- ZINC ZINC20 ZINC8816280 →
- UniProt UniProt C4LW95 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC8816280”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04217.
PDB 5
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 16
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).